Research ExplorerPublicationsOral anticoagulation in device-detected atrial fibrillation:...

Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial

  • Gregory Y H Lip (Shared first author)
  • Julius Nikorowitsch (Shared first author)
  • Susanne Sehner
  • Nina Becher
  • Emanuele Bertaglia
  • Carina Blomstrom-Lundqvist
  • Axel Brandes
  • Vincent Beuger
  • Melanie Calvert
  • A John Camm
  • Gregory Chlouverakis
  • Gheorghe-Andrei Dan
  • Wolfgang Dichtl
  • Hans Christoph Diener
  • Alexander Fierenz
  • Andreas Goette
  • Joris R de Groot
  • Astrid Hermans
  • Andrzej Lubinski
  • Eloi Marijon
  • Béla Merkely
  • Lluís Mont
  • Ann-Kathrin Ozga
  • Kim Rajappan
  • Andrea Sarkozy
  • Daniel Scherr
  • Renate B Schnabel
  • Ulrich Schotten
  • Emmanuel Simantirakis
  • Tobias Toennis
  • Panos Vardas
  • Dan Wichterle
  • Antonia Zapf
  • Paulus Kirchhof
  • NOAH-AFNET 6 Investigators

Related Research units

Bibliographical data

Original languageEnglish
ISSN0195-668X
DOIs
Publication statusPublished - 21.05.2024
PubMed 38591192

projects

Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial High Rate Episodes

Project: Research

View all (1)